{"id":87297,"date":"2026-11-19T09:21:37","date_gmt":"2026-11-19T08:21:37","guid":{"rendered":"https:\/\/www.embl.org\/news\/?p=87297"},"modified":"2026-11-19T09:21:40","modified_gmt":"2026-11-19T08:21:40","slug":"a-new-chapter-for-genecore","status":"publish","type":"post","link":"https:\/\/www.embl.org\/news\/people-perspectives\/a-new-chapter-for-genecore\/","title":{"rendered":"A new chapter for GeneCore"},"content":{"rendered":"\n<p class=\"wp-block-paragraph\">EMBL&#8217;s Genomics Core Facility \u2013 GeneCore \u2013 has been providing cutting-edge genomics services to researchers worldwide for over 20 years. After a long, illustrious career at EMBL, Vladimir Benes will step down at the end of 2026 after leading the facility since its inception. Arnaud Krebs, EMBL Group Leader, will take the reins of the facility, which has played a key role in enabling several important biological discoveries in the last two decades.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">We caught up with Krebs for his thoughts on the transition, the kind of biological questions genomics can answer, and how GeneCore is preparing for the ongoing AI revolution.&nbsp;<\/p>\n\n\n\n<h3 class=\"wp-block-heading\"><strong>What role do genomics core facilities like GeneCore play in enabling life science research?<\/strong><\/h3>\n\n\n\n<p class=\"wp-block-paragraph\">Genomics originally developed as a way to study genes and their regulation, moving from investigating individual genes to understanding how entire genomes function. Over the years, however, genomics has transformed many other fields of biology by bringing an unprecedented scale to experimental approaches.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">One of the most powerful developments has been the ability to use DNA or RNA sequencing as a universal readout for experiments. By attaching DNA barcodes to biological samples or experimental conditions, we can now measure thousands or even millions of events in parallel. This has enabled an extraordinary range of approaches, from CRISPR screens that systematically investigate gene function and the non-coding genome, to epigenomic profiling that reveals how genomes are regulated, and metagenomics, which allows us to study complex microbial communities without the need to culture individual organisms.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Facilities like GeneCore make these technologies accessible to scientists who would otherwise lack the expertise or infrastructure to implement them. Beyond providing sequencing services, they help researchers design experiments and bring genomics into entirely new areas of biology.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">EMBL has a long and pioneering history in genomics, which we recently highlighted in <a href=\"https:\/\/www.embl.org\/news\/science-technology\/speaking-the-language-of-dna\/\">an article<\/a> written with Eileen Furlong, Head of Genome Biology Unit at EMBL Heidelberg, and Ewan Birney, Director of EMBL-EBI.&nbsp;<\/p>\n\n\n\n<h3 class=\"wp-block-heading\"><strong>How has genomics research been changing in recent years?<\/strong><\/h3>\n\n\n\n<p class=\"wp-block-paragraph\">Over the past 20 years, sequencing capacity has increased dramatically while costs have fallen. This has opened the door to previously unimaginable applications, such as studying biological processes at single-cell resolution or detecting rare genetic mutations and epigenetic changes that accumulate throughout an individual&#8217;s lifetime, helping us understand processes such as ageing or disease progression. It is not only the scale that has been revolutionised, but also the sensitivity and accuracy. Genomics is now quantitative, and regulatory events can be measured at base-pair resolution, giving insights into molecular mechanisms that regulate genome function.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">One of the most exciting recent breakthroughs has been the emergence of long-read and direct sequencing technologies. These are changing not only the scale of genomics but also the nature of the questions we can ask.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">For example, they have enabled the assembly of complete telomere-to-telomere genomes, including previously inaccessible regions such as centromeres, which are essential for chromosome segregation during cell division. We can now begin to study these regions and their functions in the context of the entire genome.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Long-read technologies have also given rise to a new field \u2013 single-molecule genomics \u2013 allowing us to measure multiple regulatory events along the same DNA molecule and understand how they interact. This is particularly exciting because biological regulation is fundamentally combinatorial, yet until recently we could only study many of these events independently.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">We are still at an early stage, with new applications emerging constantly. I believe the potential is enormous.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\"><strong>Which of these new developments are you most excited about?<\/strong><\/h3>\n\n\n\n<p class=\"wp-block-paragraph\">I am excited by the growing potential of long-read and direct sequencing technologies. Promoting their adoption will be one of my priorities at GeneCore because they offer unique opportunities to address biological questions that were previously difficult or impossible to investigate. This is particularly true at EMBL, as these technologies will make genomics possible in many previously challenging organisms.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Another priority is the emerging revolution in how we interpret genomics data. Deep learning models are beginning to capture the complexity of genome regulation and identify generalisable patterns that have been extremely challenging to uncover using conventional approaches. In collaboration with EMBL&#8217;s Data Science Centre, I would like to make these models more accessible to GeneCore users and help them design experiments tailored towards this new phase of genomics. I believe this will transform the way we address questions in the future.&nbsp;<\/p>\n\n\n\n<h3 class=\"wp-block-heading\"><strong>How will GeneCore keep abreast of these evolving fields?<\/strong><\/h3>\n\n\n\n<p class=\"wp-block-paragraph\">Genomics is a particularly challenging field because innovation happens simultaneously at several levels: sequencing instruments are constantly evolving, new experimental methods are being developed, and computational approaches are becoming increasingly sophisticated.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">My experience running a research group alongside GeneCore will be a real advantage here. I started my PhD around the time the first Illumina Genome Analyser instruments emerged, and over the past 20 years, my research has relied heavily on early adoption and integration of new genomics technologies.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">I would like to bring this culture of technology scouting and experimentation to GeneCore, building on the strong foundations established by Vladimir. I also hope to encourage researchers to come to us with ambitious scientific questions, including those for which no established technology or workflow exists yet. These challenges are often what drive the most exciting technological developments.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\"><strong>What are your current priorities and what should users expect from the next phase of GeneCore?<\/strong><\/h3>\n\n\n\n<p class=\"wp-block-paragraph\">One of EMBL\u2019s strengths is the extraordinary diversity of its research. Our users at EMBL and across member states have very different needs and levels of expertise, from scientists using genomics occasionally to groups developing highly sophisticated genomics protocols. GeneCore must continue to provide reliable, high-quality, and timely services to researchers across EMBL sites and member states. Equally important is maintaining the tradition of expert scientific consultation and training that has been central to the facility&#8217;s success.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Moreover, I want to prepare GeneCore for the AI revolution. EMBL is a powerhouse of scientific data generation. Generation of unique datasets will be the most valuable currency in the future. However, data alone are not sufficient; we need high-quality annotation and experimental metadata to interpret them. I want to modernise our computational infrastructure to ensure sequencing data, sample information, and experimental metadata are systematically connected, organised, and accessible. Stronger interactions with EMBL&#8217;s <a href=\"https:\/\/www.embl.org\/groups\/modis\/\">MODIS<\/a> team, data science community, and EMBL-EBI will be essential.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">We also need to strengthen GeneCore&#8217;s capacity for technology development. I would like to create opportunities to host ambitious projects that require sustained development, in partnership with EMBL research groups and scientists from our member states. By hosting fellows in an expert ecosystem, with access to cutting-edge instrumentation, GeneCore could become an even stronger environment for developing and disseminating new genomics technologies.<\/p>\n\n\n\n<figure class=\"vf-figure wp-block-image size-full\"><img loading=\"lazy\" decoding=\"async\" width=\"1000\" height=\"600\" class=\"vf-figure__image\" src=\"https:\/\/www.embl.org\/news\/wp-content\/uploads\/2026\/11\/VladimirBenesArnaudKrebs.jpg\" alt=\"Two male scientists in lab coats in a lab.\" class=\"wp-image-87321\" srcset=\"https:\/\/www.embl.org\/news\/wp-content\/uploads\/2026\/11\/VladimirBenesArnaudKrebs.jpg 1000w, https:\/\/www.embl.org\/news\/wp-content\/uploads\/2026\/11\/VladimirBenesArnaudKrebs-767x460.jpg 767w, https:\/\/www.embl.org\/news\/wp-content\/uploads\/2026\/11\/VladimirBenesArnaudKrebs-300x180.jpg 300w\" sizes=\"auto, (max-width: 1000px) 100vw, 1000px\" \/><figcaption class=\"vf-figure__caption\">Arnaud Krebs (left) will succeed Vladimir Benes (right), who has led GeneCore for over two decades. Credit: Joseph Franciosa\/EMBL<\/figcaption><\/figure>\n\n\n\n<h3 class=\"wp-block-heading\"><strong>You will succeed Vladimir Benes, who has led the facility since its founding. How do you view this transition, and what lessons will you take forward?<\/strong><\/h3>\n\n\n\n<p class=\"wp-block-paragraph\">These are certainly big shoes to fill!<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">First, I would like to pay tribute to Vladimir, who has built GeneCore from scratch into one of Europe&#8217;s leading genomics facilities. Over more than two decades, he has successfully guided the facility through a remarkable technological revolution, from the early days of microarrays, through to tiling arrays, and then adapting continuously as sequencing technologies and their applications transformed.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">What I find particularly inspiring is his dedication to helping scientists. Generations of researchers at EMBL and across its member states have benefited from his expertise, advice, and willingness to find solutions to challenging problems. He has set an exceptionally high standard for what a core facility can achieve, both scientifically and in the support it provides to its users.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">My ambition is to build on this legacy, preserving the combination of accessible, expert support, and cutting-edge technology that has made GeneCore so successful, while preparing the facility for the next generation of genomics.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\"><strong>How has your scientific background prepared you for this role?<\/strong><\/h3>\n\n\n\n<p class=\"wp-block-paragraph\">I have worked in genomics since my PhD, witnessing the transition from microarrays to high-throughput sequencing and, more recently, the emergence of single-molecule technologies.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Throughout my career, I have used a broad range of genomics approaches across different organisms, including flies, mice, and humans. My research group has also contributed to pioneering developments in single-molecule genomics.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">One aspect of my background that I think is particularly valuable is my dual training in experimental molecular biology and computational genomics. It allows me to understand the entire process, from formulating a biological question and designing an experiment to generating, analysing, and interpreting the data.&nbsp;<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">I believe this broad perspective will be essential for supporting GeneCore users, identifying emerging opportunities, and deciding which technologies the facility should invest in.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\"><strong>What are you most looking forward to in this new role?<\/strong><\/h3>\n\n\n\n<p class=\"wp-block-paragraph\">What excites me most is the opportunity to work with scientists on a much broader range of biological questions.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Running a research group naturally means focusing on a relatively specialised set of questions. Leading GeneCore will give me the opportunity to engage with very different scientific fields and challenges.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">What motivates me most in science is the possibility of making an impact. I believe genomics has enormous transformative potential, particularly in areas where these technologies are not yet widely adopted.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">I look forward to discussing new questions with users, bringing fresh perspectives to their projects, and finding unexpected applications for emerging technologies.&nbsp;<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Arnaud Krebs, who now leads EMBL&#8217;s Genomics Core Facility, discusses the importance of genomics in enabling biological discovery and shares what&#8217;s next for the service.<\/p>\n","protected":false},"author":124,"featured_media":87345,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[17593],"tags":[384,386,42,554,2032],"embl_taxonomy":[18847,3744],"class_list":["post-87297","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-people-perspectives","tag-benes","tag-genecore","tag-genomics","tag-krebs","tag-sequencing","embl_taxonomy-arnaud-krebs","embl_taxonomy-genomics-core-facility"],"embl_taxonomy_terms":[{"uuid":"a:2:{i:0;s:36:\"4428d1fd-441a-4d6d-a1c5-5dcf5665f213\";i:1;s:36:\"904551c1-2283-4307-bdb9-ed8298241562\";}","parents":[],"name":["Arnaud Krebs"],"slug":"arnaud-krebs","description":"Who &gt; Arnaud Krebs","deprecated":true},{"uuid":"a:3:{i:0;s:36:\"302cfdf7-365b-462a-be65-82c7b783ebf7\";i:1;s:36:\"ef0437fc-a5b7-4c73-bcfd-63bff16cb35e\";i:2;s:36:\"cb2598c2-41a0-4a75-945b-b058bc2a1e75\";}","parents":[],"name":["Genomics Core Facility"],"slug":"genomics-core-facility","description":"What &gt; Services and facilities &gt; Genomics Core Facility"}],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.8 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>A new chapter for GeneCore | EMBL<\/title>\n<meta name=\"description\" content=\"Arnaud Krebs, who now leads EMBL&#039;s Genomics Core Facility, discusses the importance of genomics in enabling biological discovery and shares what&#039;s next for the service.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.embl.org\/news\/people-perspectives\/a-new-chapter-for-genecore\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"A new chapter for GeneCore | EMBL\" \/>\n<meta property=\"og:description\" content=\"Arnaud Krebs, who now leads EMBL&#039;s Genomics Core Facility, discusses the importance of genomics in enabling biological discovery and shares what&#039;s next for the service.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.embl.org\/news\/people-perspectives\/a-new-chapter-for-genecore\/\" \/>\n<meta property=\"og:site_name\" content=\"EMBL\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/embl.org\/\" \/>\n<meta property=\"article:published_time\" content=\"2026-11-19T08:21:37+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-11-19T08:21:40+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.embl.org\/news\/wp-content\/uploads\/2026\/11\/FeaturedArnaudKrebs_edited.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1000\" \/>\n\t<meta property=\"og:image:height\" content=\"600\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Shreya Ghosh\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@embl\" \/>\n<meta name=\"twitter:site\" content=\"@embl\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Shreya Ghosh\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"8 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"NewsArticle\",\"@id\":\"https:\\\/\\\/www.embl.org\\\/news\\\/people-perspectives\\\/a-new-chapter-for-genecore\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.embl.org\\\/news\\\/people-perspectives\\\/a-new-chapter-for-genecore\\\/\"},\"author\":{\"name\":\"Shreya Ghosh\",\"@id\":\"https:\\\/\\\/www.embl.org\\\/news\\\/#\\\/schema\\\/person\\\/de071e57de42c03b5f23d1e391048fb2\"},\"headline\":\"A new chapter for GeneCore\",\"datePublished\":\"2026-11-19T08:21:37+00:00\",\"dateModified\":\"2026-11-19T08:21:40+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.embl.org\\\/news\\\/people-perspectives\\\/a-new-chapter-for-genecore\\\/\"},\"wordCount\":1575,\"publisher\":{\"@id\":\"https:\\\/\\\/www.embl.org\\\/news\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/www.embl.org\\\/news\\\/people-perspectives\\\/a-new-chapter-for-genecore\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.embl.org\\\/news\\\/wp-content\\\/uploads\\\/2026\\\/11\\\/FeaturedArnaudKrebs_edited.jpg\",\"keywords\":[\"benes\",\"genecore\",\"genomics\",\"krebs\",\"sequencing\"],\"articleSection\":[\"People &amp; Perspectives\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.embl.org\\\/news\\\/people-perspectives\\\/a-new-chapter-for-genecore\\\/\",\"url\":\"https:\\\/\\\/www.embl.org\\\/news\\\/people-perspectives\\\/a-new-chapter-for-genecore\\\/\",\"name\":\"A new chapter for GeneCore | EMBL\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.embl.org\\\/news\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.embl.org\\\/news\\\/people-perspectives\\\/a-new-chapter-for-genecore\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.embl.org\\\/news\\\/people-perspectives\\\/a-new-chapter-for-genecore\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.embl.org\\\/news\\\/wp-content\\\/uploads\\\/2026\\\/11\\\/FeaturedArnaudKrebs_edited.jpg\",\"datePublished\":\"2026-11-19T08:21:37+00:00\",\"dateModified\":\"2026-11-19T08:21:40+00:00\",\"description\":\"Arnaud Krebs, who now leads EMBL's Genomics Core Facility, discusses the importance of genomics in enabling biological discovery and shares what's next for the service.\",\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.embl.org\\\/news\\\/people-perspectives\\\/a-new-chapter-for-genecore\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.embl.org\\\/news\\\/people-perspectives\\\/a-new-chapter-for-genecore\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.embl.org\\\/news\\\/wp-content\\\/uploads\\\/2026\\\/11\\\/FeaturedArnaudKrebs_edited.jpg\",\"contentUrl\":\"https:\\\/\\\/www.embl.org\\\/news\\\/wp-content\\\/uploads\\\/2026\\\/11\\\/FeaturedArnaudKrebs_edited.jpg\",\"width\":1000,\"height\":600,\"caption\":\"Arnaud Krebs, EMBL Group Leader, will take the reins of EMBL's genomics core facility GeneCore. Credit: Joseph Franciosa\\\/EMBL\"},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.embl.org\\\/news\\\/#website\",\"url\":\"https:\\\/\\\/www.embl.org\\\/news\\\/\",\"name\":\"European Molecular Biology Laboratory News\",\"description\":\"News from the European Molecular Biology Laboratory\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.embl.org\\\/news\\\/#organization\"},\"alternateName\":\"EMBL News\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.embl.org\\\/news\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.embl.org\\\/news\\\/#organization\",\"name\":\"European Molecular Biology Laboratory\",\"alternateName\":\"EMBL\",\"url\":\"https:\\\/\\\/www.embl.org\\\/news\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.embl.org\\\/news\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/www.embl.org\\\/news\\\/wp-content\\\/uploads\\\/2025\\\/09\\\/EMBL_logo_colour-1-300x144-1.png\",\"contentUrl\":\"https:\\\/\\\/www.embl.org\\\/news\\\/wp-content\\\/uploads\\\/2025\\\/09\\\/EMBL_logo_colour-1-300x144-1.png\",\"width\":300,\"height\":144,\"caption\":\"European Molecular Biology Laboratory\"},\"image\":{\"@id\":\"https:\\\/\\\/www.embl.org\\\/news\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/embl.org\\\/\",\"https:\\\/\\\/x.com\\\/embl\",\"https:\\\/\\\/www.instagram.com\\\/embl_org\\\/\",\"https:\\\/\\\/www.linkedin.com\\\/company\\\/15813\\\/\",\"https:\\\/\\\/www.youtube.com\\\/user\\\/emblmedia\\\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.embl.org\\\/news\\\/#\\\/schema\\\/person\\\/de071e57de42c03b5f23d1e391048fb2\",\"name\":\"Shreya Ghosh\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/7005cc910e37c4ca96a1b1e99e49ff50b20491aff5599e8b02b94f862665a4c4?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/7005cc910e37c4ca96a1b1e99e49ff50b20491aff5599e8b02b94f862665a4c4?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/7005cc910e37c4ca96a1b1e99e49ff50b20491aff5599e8b02b94f862665a4c4?s=96&d=mm&r=g\",\"caption\":\"Shreya Ghosh\"},\"url\":\"https:\\\/\\\/www.embl.org\\\/news\\\/author\\\/shreya-ghoshembl-de\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"A new chapter for GeneCore | EMBL","description":"Arnaud Krebs, who now leads EMBL's Genomics Core Facility, discusses the importance of genomics in enabling biological discovery and shares what's next for the service.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.embl.org\/news\/people-perspectives\/a-new-chapter-for-genecore\/","og_locale":"en_US","og_type":"article","og_title":"A new chapter for GeneCore | EMBL","og_description":"Arnaud Krebs, who now leads EMBL's Genomics Core Facility, discusses the importance of genomics in enabling biological discovery and shares what's next for the service.","og_url":"https:\/\/www.embl.org\/news\/people-perspectives\/a-new-chapter-for-genecore\/","og_site_name":"EMBL","article_publisher":"https:\/\/www.facebook.com\/embl.org\/","article_published_time":"2026-11-19T08:21:37+00:00","article_modified_time":"2026-11-19T08:21:40+00:00","og_image":[{"width":1000,"height":600,"url":"https:\/\/www.embl.org\/news\/wp-content\/uploads\/2026\/11\/FeaturedArnaudKrebs_edited.jpg","type":"image\/jpeg"}],"author":"Shreya Ghosh","twitter_card":"summary_large_image","twitter_creator":"@embl","twitter_site":"@embl","twitter_misc":{"Written by":"Shreya Ghosh","Est. reading time":"8 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"NewsArticle","@id":"https:\/\/www.embl.org\/news\/people-perspectives\/a-new-chapter-for-genecore\/#article","isPartOf":{"@id":"https:\/\/www.embl.org\/news\/people-perspectives\/a-new-chapter-for-genecore\/"},"author":{"name":"Shreya Ghosh","@id":"https:\/\/www.embl.org\/news\/#\/schema\/person\/de071e57de42c03b5f23d1e391048fb2"},"headline":"A new chapter for GeneCore","datePublished":"2026-11-19T08:21:37+00:00","dateModified":"2026-11-19T08:21:40+00:00","mainEntityOfPage":{"@id":"https:\/\/www.embl.org\/news\/people-perspectives\/a-new-chapter-for-genecore\/"},"wordCount":1575,"publisher":{"@id":"https:\/\/www.embl.org\/news\/#organization"},"image":{"@id":"https:\/\/www.embl.org\/news\/people-perspectives\/a-new-chapter-for-genecore\/#primaryimage"},"thumbnailUrl":"https:\/\/www.embl.org\/news\/wp-content\/uploads\/2026\/11\/FeaturedArnaudKrebs_edited.jpg","keywords":["benes","genecore","genomics","krebs","sequencing"],"articleSection":["People &amp; Perspectives"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.embl.org\/news\/people-perspectives\/a-new-chapter-for-genecore\/","url":"https:\/\/www.embl.org\/news\/people-perspectives\/a-new-chapter-for-genecore\/","name":"A new chapter for GeneCore | EMBL","isPartOf":{"@id":"https:\/\/www.embl.org\/news\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.embl.org\/news\/people-perspectives\/a-new-chapter-for-genecore\/#primaryimage"},"image":{"@id":"https:\/\/www.embl.org\/news\/people-perspectives\/a-new-chapter-for-genecore\/#primaryimage"},"thumbnailUrl":"https:\/\/www.embl.org\/news\/wp-content\/uploads\/2026\/11\/FeaturedArnaudKrebs_edited.jpg","datePublished":"2026-11-19T08:21:37+00:00","dateModified":"2026-11-19T08:21:40+00:00","description":"Arnaud Krebs, who now leads EMBL's Genomics Core Facility, discusses the importance of genomics in enabling biological discovery and shares what's next for the service.","inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.embl.org\/news\/people-perspectives\/a-new-chapter-for-genecore\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.embl.org\/news\/people-perspectives\/a-new-chapter-for-genecore\/#primaryimage","url":"https:\/\/www.embl.org\/news\/wp-content\/uploads\/2026\/11\/FeaturedArnaudKrebs_edited.jpg","contentUrl":"https:\/\/www.embl.org\/news\/wp-content\/uploads\/2026\/11\/FeaturedArnaudKrebs_edited.jpg","width":1000,"height":600,"caption":"Arnaud Krebs, EMBL Group Leader, will take the reins of EMBL's genomics core facility GeneCore. Credit: Joseph Franciosa\/EMBL"},{"@type":"WebSite","@id":"https:\/\/www.embl.org\/news\/#website","url":"https:\/\/www.embl.org\/news\/","name":"European Molecular Biology Laboratory News","description":"News from the European Molecular Biology Laboratory","publisher":{"@id":"https:\/\/www.embl.org\/news\/#organization"},"alternateName":"EMBL News","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.embl.org\/news\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/www.embl.org\/news\/#organization","name":"European Molecular Biology Laboratory","alternateName":"EMBL","url":"https:\/\/www.embl.org\/news\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.embl.org\/news\/#\/schema\/logo\/image\/","url":"https:\/\/www.embl.org\/news\/wp-content\/uploads\/2025\/09\/EMBL_logo_colour-1-300x144-1.png","contentUrl":"https:\/\/www.embl.org\/news\/wp-content\/uploads\/2025\/09\/EMBL_logo_colour-1-300x144-1.png","width":300,"height":144,"caption":"European Molecular Biology Laboratory"},"image":{"@id":"https:\/\/www.embl.org\/news\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/embl.org\/","https:\/\/x.com\/embl","https:\/\/www.instagram.com\/embl_org\/","https:\/\/www.linkedin.com\/company\/15813\/","https:\/\/www.youtube.com\/user\/emblmedia\/"]},{"@type":"Person","@id":"https:\/\/www.embl.org\/news\/#\/schema\/person\/de071e57de42c03b5f23d1e391048fb2","name":"Shreya Ghosh","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/7005cc910e37c4ca96a1b1e99e49ff50b20491aff5599e8b02b94f862665a4c4?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/7005cc910e37c4ca96a1b1e99e49ff50b20491aff5599e8b02b94f862665a4c4?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/7005cc910e37c4ca96a1b1e99e49ff50b20491aff5599e8b02b94f862665a4c4?s=96&d=mm&r=g","caption":"Shreya Ghosh"},"url":"https:\/\/www.embl.org\/news\/author\/shreya-ghoshembl-de\/"}]}},"field_target_display":"embl","field_article_language":{"value":"english","label":"English"},"fimg_url":"https:\/\/www.embl.org\/news\/wp-content\/uploads\/2026\/11\/FeaturedArnaudKrebs_edited.jpg","featured_image_src":"https:\/\/www.embl.org\/news\/wp-content\/uploads\/2026\/11\/FeaturedArnaudKrebs_edited.jpg","acf":{"vfwp-news_embl_taxonomy":[3744,18847],"featured":true,"show_featured_image":false,"field_target_display":"embl","field_article_language":{"value":"english","label":"English"},"article_intro":"<p>EMBL&#8217;s Genomics Core Facility has a new leader, Arnaud Krebs, who discusses the importance of genomics in enabling biological discovery and shares what&#8217;s next for the service<\/p>\n","related_links":[{"link_description":"EMBL GeneCore","link_url":"https:\/\/www.embl.org\/groups\/genomics\/"},{"link_description":"Embracing the genome sequencing revolution\r\n","link_url":"https:\/\/www.embl.org\/news\/embletc\/issue-101\/embracing-the-genome-sequencing-revolution\/"},{"link_description":"Speaking the language of DNA\r\n","link_url":"https:\/\/www.embl.org\/news\/science-technology\/speaking-the-language-of-dna\/"}],"source_article":false,"in_this_article":false,"press_contact":"None","article_translations":false,"languages":""},"_links":{"self":[{"href":"https:\/\/www.embl.org\/news\/wp-json\/wp\/v2\/posts\/87297","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.embl.org\/news\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.embl.org\/news\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.embl.org\/news\/wp-json\/wp\/v2\/users\/124"}],"replies":[{"embeddable":true,"href":"https:\/\/www.embl.org\/news\/wp-json\/wp\/v2\/comments?post=87297"}],"version-history":[{"count":9,"href":"https:\/\/www.embl.org\/news\/wp-json\/wp\/v2\/posts\/87297\/revisions"}],"predecessor-version":[{"id":87351,"href":"https:\/\/www.embl.org\/news\/wp-json\/wp\/v2\/posts\/87297\/revisions\/87351"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.embl.org\/news\/wp-json\/wp\/v2\/media\/87345"}],"wp:attachment":[{"href":"https:\/\/www.embl.org\/news\/wp-json\/wp\/v2\/media?parent=87297"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.embl.org\/news\/wp-json\/wp\/v2\/categories?post=87297"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.embl.org\/news\/wp-json\/wp\/v2\/tags?post=87297"},{"taxonomy":"embl_taxonomy","embeddable":true,"href":"https:\/\/www.embl.org\/news\/wp-json\/wp\/v2\/embl_taxonomy?post=87297"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}